The Who, What, Why’s of Lupus
Three lupus experts from Jacobi Medical Center answered these common questions at an educational seminar co-sponsored by the Lupus...
News
Advancing Lupus Care Through Research and Advocacy Conference
The First Collaborative Conference a Great Success
The Lupus Research Alliance and Lupus Foundation New England recently co-hosted the Advancing...
Make Your Voice Heard on Lupus Drug Development
The national lupus patient advocacy community is excited to announce that people with lupus will have the chance to be...
Novel Research Grants Push Discoveries
10 New Grants, 10 New Insights
The path to safe and effective treatments and ultimately a cure lies in bold,...
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global...